Mylotarg
NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia
October 8, 2018Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma
NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …
Pfizer’s drug back on the market after proving safety
September 5, 2017Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical
Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …
Reaxa spins out specialist antibody-drug conjugate unit
October 19, 2010Manufacturing and Production Mylotarg, Reaxa, antibody-drug conjugates
UK company Reaxa is spinning out a new company called ADC Biotechnology to develop and commercialise an improved purification technology …
Pfizer withdraws blood cancer drug in US
June 22, 2010Sales and Marketing AML, Mylotarg, Pfizer, blood cancer
The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …
